GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Luyan Pharma Co Ltd (SZSE:002788) » Definitions » Retained Earnings

Luyan Pharma Co (SZSE:002788) Retained Earnings : ¥1,807 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Luyan Pharma Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Luyan Pharma Co's retained earnings for the quarter that ended in Mar. 2024 was ¥1,807 Mil.

Luyan Pharma Co's quarterly retained earnings increased from Sep. 2023 (¥1,637 Mil) to Dec. 2023 (¥1,724 Mil) and increased from Dec. 2023 (¥1,724 Mil) to Mar. 2024 (¥1,807 Mil).

Luyan Pharma Co's annual retained earnings increased from Dec. 2021 (¥1,292 Mil) to Dec. 2022 (¥1,491 Mil) and increased from Dec. 2022 (¥1,491 Mil) to Dec. 2023 (¥1,724 Mil).


Luyan Pharma Co Retained Earnings Historical Data

The historical data trend for Luyan Pharma Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luyan Pharma Co Retained Earnings Chart

Luyan Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 915.39 1,112.86 1,291.51 1,491.27 1,723.57

Luyan Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,571.13 1,563.73 1,636.69 1,723.57 1,807.34

Luyan Pharma Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Luyan Pharma Co  (SZSE:002788) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Luyan Pharma Co (SZSE:002788) Business Description

Traded in Other Exchanges
N/A
Address
1004 Ridge Road, Huli District, Fujian Province, Xiamen City, CHN, 361 010
Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.
Executives
Zhu Ming Guo Executives
Yang Cong Jin Directors, executives
Lei Ming Directors, executives
Li Wei Yang Executives
Cai Mei Zhen Supervisors
Li Cui Ping Supervisors
Wu Jin Xiang Directors, executives
Zhang Jun Ying Executives
Wu Huo Lu Director

Luyan Pharma Co (SZSE:002788) Headlines

No Headlines